📰 1 source covering this story

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

Compare how each outlet is covering it — and rate the sources you trust.

Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.

Trust?Read on NYT Health ↗